Type 1 diabetes is a chronic condition in which the immune system destroys the cells in the pancreas that produce insulin. Without insulin, your body can’t move sugar from the bloodstream into cells for energy, so blood sugar rises to dangerous levels. Unlike type 2 diabetes, which involves insulin resistance, type 1 results from an absolute loss of insulin production and requires lifelong insulin replacement. It can appear at any age, though it’s most commonly diagnosed in children and young adults.
What Happens Inside the Body
Your pancreas contains clusters of cells called islets, and within those islets are beta cells, which are the only cells that manufacture insulin. In type 1 diabetes, the immune system treats these beta cells as foreign invaders and sends white blood cells to attack them. The destruction is surprisingly subtle. Fewer than 10% of islets typically become infiltrated, and it takes as few as 15 immune cells per islet to cause damage. But over months or years, this low-grade assault wipes out enough beta cells that the pancreas can no longer keep up with the body’s insulin needs.
There’s a genetic component. Certain gene variants, particularly those related to the immune system and insulin production, increase susceptibility. But genetics alone don’t explain it. Researchers believe some initial trigger, possibly a viral infection or environmental factor, causes early beta cell damage. That damage may activate immune cells that then escalate the attack. The process can begin years before any symptoms appear.
Three Stages Before Diagnosis
Type 1 diabetes doesn’t begin the day you start feeling sick. It progresses through three defined stages, and understanding them matters because earlier detection is now possible through blood testing.
- Stage 1: Two or more diabetes-related autoantibodies are present in the blood, but blood sugar levels are still normal and there are no symptoms.
- Stage 2: Autoantibodies are still present, and blood sugar levels have become abnormal, but there are still no noticeable symptoms.
- Stage 3: Blood sugar is high, symptoms are present, and this is when most people receive their diagnosis.
A simple blood test can detect autoantibodies well before symptoms develop. If two or more autoantibodies are confirmed on repeat testing, it means the autoimmune process has already started, even if blood sugar is still normal. This is especially relevant for people with a family history of type 1 diabetes, since screening can give families and doctors a head start on monitoring and preparation.
Symptoms That Appear Quickly
Unlike type 2 diabetes, which develops gradually, type 1 symptoms can appear suddenly over days or weeks. The classic signs include feeling much thirstier than usual, urinating frequently, losing weight without trying, feeling extremely hungry, blurry vision, and persistent fatigue and weakness. Children who have never wet the bed may start doing so. Irritability and mood changes are also common, particularly in kids.
These symptoms happen because without insulin, glucose builds up in the blood instead of entering cells. Your kidneys try to filter out the excess sugar, pulling water along with it, which causes frequent urination and dehydration. Your cells, starved of their energy source, signal for more food, and your body begins breaking down fat and muscle for fuel, leading to weight loss.
Diabetic Ketoacidosis: The Urgent Risk
When the body can’t use glucose for energy, it breaks down fat at an accelerated rate, producing acids called ketones. If ketones accumulate faster than the body can clear them, the blood becomes dangerously acidic. This is diabetic ketoacidosis (DKA), and it’s a medical emergency. DKA is defined by blood sugar above 250 mg/dL, blood pH below 7.3, and elevated ketone levels.
Symptoms of DKA include nausea and vomiting, abdominal pain, fruity-smelling breath, rapid breathing, and confusion. DKA is often the event that leads to a first-time type 1 diagnosis, especially in children whose earlier symptoms were missed. It can also occur in people who already have a diagnosis if they miss insulin doses, get sick, or experience pump failures.
How Insulin Therapy Works
Everyone with type 1 diabetes needs external insulin, delivered either through injections or an insulin pump. Most people use a combination of two types: a long-acting insulin that provides a steady background level throughout the day, and a rapid-acting insulin taken before meals to handle the incoming sugar from food.
Rapid-acting insulin starts working within about 15 minutes, peaks at one hour, and lasts two to four hours. Long-acting insulin kicks in after about two hours, doesn’t have a sharp peak, and works for up to 24 hours. There’s also an inhaled rapid-acting form that begins working in 10 to 15 minutes and lasts about three hours. Getting the timing and doses right is an ongoing process that changes with activity levels, stress, illness, and what you eat.
Counting Carbs and Calculating Doses
Carbohydrates have the biggest impact on blood sugar, so people with type 1 diabetes learn to count the grams of carbohydrates in every meal and calculate how much rapid-acting insulin to take. This is based on a personal insulin-to-carb ratio. For example, if your ratio is 1:10, you’d take one unit of insulin for every 10 grams of carbohydrate. Someone eating a 60-gram-carb lunch with that ratio would take 6 units.
These ratios vary widely, from 1:4 to 1:30 or more, depending on individual insulin sensitivity. A general starting point is that one unit covers about 12 to 15 grams of carbohydrate, but the number gets fine-tuned over time with your care team. On top of the meal dose, you may also need a correction dose if your blood sugar is already running high before eating. This daily math becomes second nature for most people, but it never fully goes away.
Monitoring Blood Sugar
Keeping blood sugar in a safe range requires frequent monitoring. The traditional method is a finger-stick glucose meter, which gives a snapshot of your blood sugar at that moment. Continuous glucose monitors (CGMs) have largely replaced finger sticks for many people. A CGM uses a tiny sensor inserted just under the skin, about the size of two stacked quarters, that reads glucose levels continuously and transmits the data to a smartphone or receiver.
The biggest advantage of a real-time CGM is its alert system. The device can warn you when blood sugar is trending too high or too low, giving you time to act before reaching a dangerous level. Many current CGMs are factory-calibrated, meaning they don’t require finger-stick calibration. Some also allow you to make insulin dosing decisions without a confirmatory finger stick. Data can be shared in real time with up to 20 people, which is particularly useful for parents monitoring a child’s levels remotely.
Managing Low Blood Sugar
Hypoglycemia, or low blood sugar, is the most common day-to-day complication of insulin therapy. Blood sugar below 70 mg/dL is considered low. Symptoms include shakiness, sweating, dizziness, confusion, and irritability. It can happen if you take too much insulin, skip a meal, or exercise more than expected.
The standard treatment is the 15-15 rule: eat or drink 15 grams of fast-acting carbohydrates (such as glucose tablets, juice, or regular soda), wait 15 minutes, then recheck your blood sugar. If it’s still below 70, repeat the process. Once your level is back in range, follow up with a balanced snack or meal that includes protein and carbohydrates to keep it stable. Severe lows that cause loss of consciousness require emergency treatment with glucagon.
Technology That Simplifies Management
Insulin pumps deliver rapid-acting insulin continuously through a small tube under the skin, eliminating the need for multiple daily injections. When paired with a CGM, some pump systems can automatically adjust insulin delivery based on real-time glucose readings. These “closed-loop” or “automated insulin delivery” systems reduce the amount of manual decision-making and can significantly improve time spent in a healthy blood sugar range, especially overnight.
The combination of a CGM and an automated pump doesn’t eliminate the need for carb counting or user input, but it handles many of the micro-adjustments that would otherwise require constant attention. For many people, this technology represents the most meaningful improvement in daily quality of life since insulin itself.
Treatments That Can Delay Onset
For people diagnosed at stage 2, before symptoms appear, there is now an immunotherapy option that can delay progression to full-blown type 1 diabetes. Teplizumab, an antibody-based treatment approved in the U.S. and Europe, works by calming the immune attack on beta cells. In clinical trials, people treated with teplizumab took a median of 50 months to progress to stage 3, compared to 25 months for those who received a placebo. That’s roughly two additional years of life without needing insulin, which is especially meaningful for children and adolescents. This treatment only applies to people identified through autoantibody screening before they develop symptoms.